Thrombogenic risk in patients with atrial fibrillation

dc.contributor.authorLim, H.
dc.contributor.authorWilloughby, S.
dc.contributor.authorSchultz, C.
dc.contributor.authorAlasady, M.
dc.contributor.authorRangnekar, G.
dc.contributor.authorDang, J.
dc.contributor.authorGan, C.
dc.contributor.authorLau, D.
dc.contributor.authorRoberts-Thomson, K.
dc.contributor.authorYoung, G.
dc.contributor.authorWorthley, M.
dc.contributor.authorSanders, P.
dc.date.issued2015
dc.description.abstractAbstract not available
dc.description.statementofresponsibilityHan S. Lim, Scott R. Willoughby, Carlee Schultz, Muayad Alasady, Geetanjali Rangnekar, Jerry Dang, Cheryl Gan, Dennis H. Lau, Kurt C. Roberts-Thomson, Glenn D. Young, Matthew I. Worthley, Prashanthan Sanders
dc.identifier.citationJACC: Clinical Electrophysiology, 2015; 1(3):210-217
dc.identifier.doi10.1016/j.jacep.2015.03.011
dc.identifier.issn2405-500X
dc.identifier.issn2405-5018
dc.identifier.orcidLim, H. [0000-0002-8532-7891]
dc.identifier.orcidSchultz, C. [0000-0002-0026-9873]
dc.identifier.orcidLau, D. [0000-0001-7753-1318] [0000-0002-1564-439X]
dc.identifier.orcidSanders, P. [0000-0003-3803-8429]
dc.identifier.urihttp://hdl.handle.net/2440/96604
dc.language.isoen
dc.publisherElsevier
dc.rights© 2015 by the American College of Cardiology Foundation.
dc.source.urihttps://doi.org/10.1016/j.jacep.2015.03.011
dc.subjectatrial fibrillation; endothelial dysfunction; left atrium; stroke prevention; thrombotic risk
dc.titleThrombogenic risk in patients with atrial fibrillation
dc.typeJournal article
pubs.publication-statusPublished

Files